Dharani Finance Limited has submitted its quarterly compliance certificate under regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The certificate was filed with the Bombay Stock Exchange on April 8, 2026.

Compliance Certificate Details

The compliance certificate was issued by Cameo Corporate Services Limited, the company's registrar and share transfer agent, on April 6, 2026. The certificate confirms adherence to regulatory requirements for dematerialization processes during the fourth quarter of fiscal year 2026.

Regulatory Compliance Confirmation

Cameo Corporate Services Limited confirmed that all securities received from depository participants for dematerialization during the quarter were properly processed. The registrar certified that securities were either accepted or rejected and confirmed to the depositories in accordance with regulatory requirements.

Key compliance aspects covered in the certificate include:

• All dematerialization requests were processed within the stipulated timeframe
• Physical security certificates were properly mutilated and cancelled after verification
• Depository names were substituted in the Register of Members as registered owners
• All procedures were completed within the mandatory 15-day period

Corporate Information

Dharani Finance Limited operates from its registered and administrative office at PGP House, Sterling Road, Nungambakkam, Chennai. The company is incorporated under CIN L65191TN1990PLC019152 and trades on the Bombay Stock Exchange under scrip code 511451.

The compliance certificate was signed by Murugavel Ramasamy, Managing Director of Dharani Finance Limited, confirming the company's adherence to SEBI depositories and participants regulations for the quarter ended March 31, 2026.

Chennai Meenakshi Multispeciality Hospital Limited has released its unaudited financial results for the quarter and nine months ended December 31, 2025, showing mixed performance with reduced quarterly losses but continued operational challenges.

Financial Performance Overview

The hospital reported improved quarterly performance despite continuing losses. Total income from operations for Q3 FY26 reached ₹937.96 lakhs, representing growth from ₹909.31 lakhs in the corresponding quarter of the previous year.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, the company demonstrated revenue growth alongside improved loss management. Total income from operations increased to ₹2810.70 lakhs from ₹2608.10 lakhs in the previous year.

Earnings Per Share and Capital Structure

The company's earnings per share reflected the operational losses across all reported periods. Basic and diluted EPS for Q3 FY26 stood at ₹-0.72 per share, compared to ₹-0.84 per share in Q3 FY25.

Corporate Governance and Compliance

The financial results were reviewed and recommended by the Audit Committee before receiving approval from the Board of Directors at their meeting held on February 11, 2026. The company has maintained compliance with SEBI regulations by filing detailed financial results with stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The complete format of the quarterly and nine-month financial results is available on the BSE website and the company's official website for stakeholder reference. The hospital continues to operate under the leadership of Chairman & Managing Director Gomathi R, focusing on multispecialty healthcare services from its registered office in Chennai.